Related Experiment Videos
Summary
Schilder disease, a rare demyelinating disorder, can present with severe neurological symptoms. Early diagnosis and treatment with corticosteroids like prednisone may lead to significant recovery in affected children.
Area of Science:
- Neuroscience
- Pediatric Neurology
- Radiology
Background:
- Schilder disease is a rare, severe demyelinating disorder affecting the central nervous system.
- It typically presents in childhood with progressive neurological deficits, including cognitive decline and visual impairment.
Observation:
- A 7-year-old girl exhibited progressive dementia and signs of increased intracranial pressure.
- Advanced neuroimaging (99mTechnetium pertechnetate brain imaging, cerebral angiograms, pneumoencephalogram) identified a large, bilateral frontal lesion crossing the corpus callosum.
Findings:
- Histological examination confirmed the diagnosis of Schilder disease.
- Postoperative prednisone therapy was initiated due to elevated intracranial pressure.
- The patient demonstrated remarkable clinical improvement, discontinuing prednisone within 4 months and excelling academically.
Implications:
- This case highlights the potential for significant neurological recovery in Schilder disease with prompt diagnosis and corticosteroid treatment.
- Early intervention may reverse severe symptoms and improve long-term cognitive function in pediatric patients.
- The findings underscore the importance of neuroimaging and timely management in demyelinating disorders.